AI

biotech

$18m investment in malaria, TB and NTD projects

Jim Cornall - July 13, 2026

biotech

Anticancer “nanoswitch” technology developed

Jim Cornall - July 13, 2026

biotech

Epigenetic mapping provides deeper insight into leukaemia

Jim Cornall - July 13, 2026

biotech

Base to Base biotech podcast 67: Synthetic DNA and crossing the blood-brain barrier

Jim Cornall - July 10, 2026

AI

Ryght AI and Biorasi to partner on AI

Jim Cornall - August 21, 2025

AI

Novel gene therapy for ALS cleared for trials in US and China

Jim Cornall - August 19, 2025

AI

Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins

Jim Cornall - August 19, 2025

AI

KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations

admin - August 11, 2025

AI

Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA

Jim Cornall - August 8, 2025

AI

Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance

Jim Cornall - July 18, 2025

AI

Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity

Jim Cornall - July 4, 2025

AI

I-Corps Hub West accelerates deeptech commercialisation in western US

Jim Cornall - June 17, 2025

123...7 Page 2 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

$18m investment in malaria, TB and NTD projects

Jim Cornall - July 13, 2026 0

The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately $18m in six R&D projects for the development of drugs...

Anticancer “nanoswitch” technology developed

biotech Jim Cornall - July 13, 2026 0

Epigenetic mapping provides deeper insight into leukaemia

biotech Jim Cornall - July 13, 2026 0

Base to Base biotech podcast 67: Synthetic DNA and crossing the blood-brain barrier

biotech Jim Cornall - July 10, 2026 0

New CRISPR method makes it possible to control protein production in cells

biotech Jim Cornall - July 9, 2026 0